Danaher (DHR) Osake Kurssi
Danaher Kurssi
Viimeisten 19 vuoden aikana Danahern liikevaihto kasvoi 5,1 % vuodessa ja ylsi 24,57 Mrd. USD:een. Osakekohtainen tulos on kasvanut 5,9 % vuodessa viimeisten 19 vuoden aikana. Danahern nettomarginaali 14,7 % on laskenut verrattuna 21,8 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,56 %. Jakosuhde on noin 25 % tuloksesta. Osinko on kasvanut 20,0 % vuodessa viimeisten 19 vuoden aikana. Danahern 12 kuukauden konsensustavoitehinta on 225,00 USD, noin ali kurssia 2,3 %. 31 analyytikosta 26 suosittaa ostoa — kokonaiskonsensus on Osta.
Danaher osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Danaher liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Danaher -osakkeesta
Danaher Corp is a multinational conglomerate that operates in the fields of scientific research, diagnostics, dental products, and environmental analysis. The company follows a decentralized business model, consisting of several strategic segments that provide specialized products and services. With a focus on innovation and continuous improvement, Danaher Corp emphasizes the development and growth of its businesses through both organic means and targeted acquisitions. By leveraging their diverse portfolio of brands and technologies, Danaher Corp aims to address critical challenges and deliver valuable solutions to their customers, while driving sustainable growth and generating long-term shareholder value.
Danaher Corp is primarily active in the industrial and healthcare sectors.
The main competitors of Danaher Corp in the market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., and PerkinElmer, Inc.
Danaher Corp, founded in 1969, is a globally recognized company specializing in science and technology solutions. Initially an environmental testing equipment manufacturer, it has since diversified its portfolio into healthcare, industrial, and consumer sectors. With a strong emphasis on innovation, Danaher has continually expanded through strategic acquisitions, fostering growth and enhancing its capabilities. The company's commitment to operational excellence has earned it a reputation for delivering high-quality products and services across its various business segments. Over the years, Danaher Corp has established itself as a leading force in the global market, driving advancements in diagnostics, life sciences, dental care, and water quality.
Danaher Corp has achieved several significant milestones throughout its history. The company's successful acquisition of various businesses and subsequent integration has greatly expanded its product portfolio and global presence. In 1984, Danaher implemented the highly regarded Danaher Business System (DBS), a continuous improvement methodology that has driven operational excellence across its businesses. In 2016, the company completed the acquisition of Pall Corporation, a global leader in filtration, separation, and purification technologies, further strengthening its position in the life sciences and diagnostics market. The following year, Danaher completed the spin-off of its industrial business into Fortive Corporation, allowing both entities to focus on their respective growth opportunities. These milestones reflect Danaher Corp's commitment to strategic growth and delivering value to its shareholders.
Danaher Corp is primarily present in multiple countries and regions worldwide. As a multinational conglomerate, the company has a wide geographic footprint. Danaher Corp operates across various countries, including the United States, Canada, Mexico, Brazil, Argentina, Chile, Germany, France, the United Kingdom, Spain, Italy, Russia, China, Japan, India, Australia, and many more. With its global presence, Danaher Corp has established itself as a leading player in multiple industries, including life sciences, diagnostics, dental, and environmental and applied solutions.
Danaher Corp is a leading global science and technology innovator committed to improving the quality of life. The company's corporate philosophy revolves around continuous improvement and leveraging their strong portfolio of businesses to drive growth and create long-term value for shareholders. With a focus on innovation, Danaher Corp places high importance on developing cutting-edge solutions across various industries, including diagnostics, life sciences, dental, environmental, and industrial markets. By emphasizing customer-centricity and operational excellence, Danaher Corp aims to provide superior products and services that address critical challenges and improve outcomes for customers worldwide.
Analyytikot asettavat tällä hetkellä Danaher-osakkeelle keskimääräisen tavoitehinnan 221,58 USD (mediaani: 225,00 USD), mikä merkitsee −3,8 % viimeisimpään hintaan verrattuna. Konsensus perustuu 31 analyytikkoarvioon.
31 analyytikkoa arvioi tällä hetkellä Danaher-osaketta: 26 suosittaa ostoa, 5 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Danaher-yhtiöltä 26,26 Mrd. USD liikevaihtoa ja 8,65 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Danaher-osake noteerataan hintaan 206,33 EUR (230,25 USD).
Danaher-osake (DHR) on listattuna 10 pörssissä, muun muassa: NYSE (DHR), London (0R2B.L), SIX (Zürich) (DHR.SW), XETRA (DAP.DE), Frankfurt (DAP.F), München (DAP.MU), Düsseldorf (DAP.DU), Wien (DHRC.VI).
The Danaher Corporation is a diversified business model with a portfolio of strategically aligned business sectors. The company develops, manufactures, and sells a variety of precision instruments and systems, as well as products and services for various applications in healthcare, environment, industry, and technology research. The key business sectors include Life Sciences, Diagnostics, Dental, Environmental & Applied Solutions, Agilent Technologies, and Pall Corporation. These divisions offer a wide range of products and services, such as medical diagnostic systems, dental instruments, environmental and water analysis devices, laboratory technologies, tools and materials for electronics manufacturing, as well as consumables and accessories for the life sciences field. Danaher also has a broad range of brands, including Cepheid, Leica Microsystems, Beckman Coulter, Hach, Esko, KaVo Kerr, ChemTreat, IDBS, Keithley, and Tektronix. These brands are leaders in their respective industries, with strong market positions and established customer bases. An important part of Danaher's business model is its management system, based on the Danaher Business System (DBS). This is a process of continuous improvement that enhances the company's efficiency and productivity. DBS is a combination of Lean Manufacturing, Six Sigma, and other innovation techniques, and has proven successful in streamlining business processes, reducing costs, and improving overall company performance. The company also has a strong global presence, with an extensive network of sales and service centers in North America, Europe, Asia, and other regions worldwide. Danaher generates a significant portion of its revenue outside the US and benefits from growing demand in emerging markets. The company also invests in research and development to develop innovative products and solutions that meet the needs of its customers. Overall, Danaher's business model is well-positioned for success in various industries and on a global scale, thanks to its diversified product range, brands, and management process. The company has proven itself by providing tailored solutions to meet its customers' needs and consistently executing its growth strategies.
odotettu liikevaihto Danaher on 26,26 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Danaher on 6,15 Mrd. USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Danaher:n hinta-voitto-suhde (P/E) on tällä hetkellä 26,62. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Danaher-osakkeen arvostusta.
Danaher:n hinta-myynti-suhde (P/S) on tällä hetkellä 6,23. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Danaher-osakkeen arvostuskennuslukuna.
Danaher:n Eulpool-laatuscore on 5/10.
Danaher:n ISIN on US2358511028. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Danaher:n WKN on 866197. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Danaher:n ticker on DHR. Tämä pörssinoteeraus käytetään Danaher-osakkeiden kauppaan pörssissä.
Danaher osake
Danaher vertaisryhmä
Danaher Ticker
Danaher FIGI
Kaikki tunnusluvut ja syvällinen analyysi Danaher:sta
Meidän osakeanalyysimme Danaher-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Danaher:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: